
QBench is a cloud LIMS that gives testing laboratories one platform for samples, workflows, data, inventory, reporting, quality processes, and client interactions.
Every stage of lab operations runs through QBench, from order placement and sample processing to results and automated reporting. Because the platform is highly configurable, labs set up their own workflows, custom data fields, and automations to match how they already work, then adjust those settings as processes change without leaning heavily on custom code.
File parsers and a robust API link QBench with instruments, software, and other systems. Data moves between them automatically, which cuts down on repetitive entry and transcription errors. For deeper reporting, labs can connect QBench to Tableau, Power BI, Domo, and Looker via REST API.
Core features:
Sample and workflow tracking
Configurable workflows and custom fields
Automation
Instrument and system integrations
File parsers and API access
Inventory management
Client portal
Automated reporting
Analytics and operational insights
Tableau, Power BI, Domo, and Looker connectivity
Built-in Quality Management System (QMS)
Rather than requiring extensive custom development to fit a lab’s processes, QBench is designed to adapt, so changes to fields, processes, and automations stay in the lab’s hands.
Running in the cloud, QBench keeps lab data, workflows, quality management, and reporting secure and centralized. Former bench scientists on the QBench team help customers through implementation and ongoing use.
Learn more
SciSure is a platform for managing laboratory operations end-to-end, built for scientific organizations. It brings together ELN, LIMS, and Health & Safety tools so teams can document experiments, track samples, manage chemical inventory, and maintain compliance workflows that are structured and audit-ready.
By replacing fragmented systems with a single governed platform, SciSure helps organizations improve reproducibility, gain clearer operational visibility, and scale lab operations with less risk.
Learn more
SciSpace BioMed Agent
SciSpace BioMed operates as a cutting-edge AI-driven "co-scientist" specifically designed for biomedical research, merging a vast collection of literature with an array of over 150 bio-tools and more than 100 academic databases and software applications to streamline complex research activities that span genomics, single-cell analysis, drug discovery, and clinical genomics. It enables researchers to interact using natural language, manage datasets, analyze genetic variants or multi-omics data, structure experimental workflows, reason through clinical biology and diseases, and create publication-ready outputs like figures, tables, and presentations while maintaining transparency and proper citation practices. Additionally, the platform features a “chat with PDF” option, allowing users to engage directly with scientific articles by highlighting text and seeking clarification on challenging material, thus serving as a valuable resource for understanding intricate methods and concepts. Moreover, for conducting literature reviews or initiating research, its AI-optimized semantic search can navigate millions of academic papers, yielding citation-supported summaries that foster a deeper comprehension of the relevant literature. This powerful functionality not only expedites the research journey but also empowers scientists to dedicate more time to their innovative discoveries rather than getting bogged down by administrative responsibilities, enhancing overall productivity in the field. Ultimately, SciSpace BioMed represents a significant advancement in how researchers approach complex biomedical inquiries, offering tools that make the research process both efficient and insightful.
Learn more
Recursion
Recursion is a pioneering TechBio company reimagining drug discovery through the integration of biology, artificial intelligence, and large-scale data. Founded more than ten years ago, Recursion introduced a novel approach that uses cellular imaging to train AI models to understand disease mechanisms. The company’s mission is to reduce the high failure rate of traditional drug development by uncovering deeper biological insights. At the core of its work is the Recursion OS, a drug discovery and development platform that unifies data, machine learning, and automated experimentation. Recursion has built one of the world’s largest proprietary biological and chemical datasets, spanning phenomics, transcriptomics, proteomics, and patient data. Its automated wet labs generate millions of experiments weekly, creating a continuous feedback loop that improves model performance. This system enables rapid identification of new drug targets and optimized molecule design. Recursion’s pipeline includes multiple programs addressing aggressive cancers and rare diseases with significant unmet needs. The company partners with pharmaceutical leaders, computational technology providers, and data innovators to extend its impact. With BioHive-2, a powerful supercomputer built with NVIDIA, Recursion processes massive datasets at unprecedented speed. These capabilities allow the company to move candidates faster from discovery to clinical trials. Overall, Recursion is focused on delivering better medicines to patients through AI-driven precision and scale.
Learn more